title: STP position paper: best practice guideline for the routine pathology evaluation of the immune system.
authors.affiliation: AstraZeneca, Wilmington, DE 19850-5437, USA.
authors.forename: P
authors.initials: P
authors.lastname: Haley
authors.forename: R
authors.initials: R
authors.lastname: Perry
authors.forename: D
authors.initials: D
authors.lastname: Ennulat
authors.forename: S
authors.initials: S
authors.lastname: Frame
authors.forename: C
authors.initials: C
authors.lastname: Johnson
authors.forename: J-M
authors.initials: JM
authors.lastname: Lapointe
authors.forename: A
authors.initials: A
authors.lastname: Nyska
authors.forename: P
authors.initials: P
authors.lastname: Snyder
authors.forename: D
authors.initials: D
authors.lastname: Walker
authors.forename: G
authors.initials: G
authors.lastname: Walter
mesh_terms: D000818:Animals; D004285:Dogs; D015507:Drugs, Investigational / Q000592:standards / Q000633:toxicity*; D007107:Immune System / Q000187:drug effects / Q000473:pathology*; D008221:Lymphoid Tissue / Q000187:drug effects / Q000473:pathology; D010338:Pathology, Clinical / Q000592:standards*; D011323:Primates; D051381:Rats; D012958:Societies, Scientific; D009626:Terminology as Topic; D018675:Toxicity Tests / Q000592:standards*
chemical_list: D015507:Drugs, Investigational